Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

By | June 22, 2021
COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization. However, there have been nagging questions about whether such antibody therapies retain their effectiveness as worrisome new virus variants arise.